Predictors of severe leptospirosis: a multicentre observational study from Central Malaysia
BMC Infectious Diseases volume 21, Article number: 1081 (2021)
Leptospirosis is a re-emerging disease with vast clinical presentations, that ranges from subclinical or mild to severe and fatal outcomes. Leptospirosis can be managed well if diagnosed earlier, however, similar clinical presentations by several other febrile illnesses or co-infections, and laboratory diagnostic challenges due to the biphasic nature of the illness, often result in mis- or underdiagnosis, thereby lead to severe illness. Identification of clinical predictors for the severe form of the disease plays a crucial role in reducing disease complication and mortality. Therefore, we aimed to determine the clinical predictors associated with severe illness among leptospirosis patients from Central Malaysia through a prospective multicenter observational study.
A prospective multicenter observational study was performed on patients admitted for clinically suspected leptospirosis. Three hospitals namely Hospital Serdang, Hospital Tengku Ampuan Rahimah and Hospital Teluk Intan were included in the study. Among a total of 165 clinically suspected leptospirosis patients, 83 confirmed cases were investigated for clinical predictors for severe illness. Qualitative variables were performed using χ2 and the relationship between mild and severe cases was evaluated using logistic regression. Multivariable logistic regression was used to predict the independent variable for severity.
Among the 83 patients, 50 showed mild disease and 33 developed severe illness. The mean age of the patients was 41.92 ± 17.99 and most were males (n = 54, 65.06%). We identified mechanical ventilation, acute kidney injury, septic shock, creatinine level of > 1.13 mg/dL, urea > 7 mmol/L, alanine aminotransferase > 50 IU, aspartate aminotransferase > 50 IU, and platelet < 150 × 109/L as factors associated with severe illness. Acute kidney injury, alanine aminotransferase > 50 IU and platelet < 150 × 109/L were defined as the independent factors for severity.
Lungs, liver and kidney involvement and septic shock were found as the prognostic factors for severe leptospirosis. Acute kidney injury, high level of alanine aminotransferase and low level of platelets were found to be independent predictors of severity.
Leptospirosis is a globally distributed zoonotic disease caused by the pathogenic species of Leptospira, a genus of spirochete bacteria. Although this disease has a worldwide distribution, it is more common in the tropics due to its favorable transmission condition. In Malaysia, leptospirosis is an endemic disease. Occasional outbreaks have been reported and are mainly associated with forest and water activities, flood and crowded living environment [1,2,3,4,5].
The clinical presentation of leptospirosis varies from mild to severe, life-threatening and fatal outcomes. The symptoms are diverse, generally include fever and often shares presentations with other infectious diseases, such as malaria, dengue, and influenza. About 90% of leptospirosis is a subclinical or self-limited febrile illness, while the severe form is presented by sepsis and multiple organ failures . The most severe form of leptospirosis is Weil’s disease, seen in 5–15% of infected cases and typically involves multiple organs damages accompanied with jaundice, acute renal failure and hemorrhage and has a fatality rate of more than 10% [7, 8]. However, leptospirosis cases with lung involvement presenting with acute respiratory distress syndrome (ARDS) or severe pulmonary hemorrhage syndrome (SPHS) have the highest mortality rates of over 70% . The presentation of leptospirosis appears to be distinct in different geographical areas worldwide . This is particularly true as different geographical location may have different prevailing Leptospira species and serovars, socio-economy and environmental conditions. The variations of intrinsic virulence among serovars and species have been asserted to partially explain the disease severity of mild and severe forms of leptospirosis . These differences may also lead to specific predictors of severe disease and mortality.
The two extreme manifestations of leptospirosis which are mild/subclinical and severe illness with mortality caution that the disease should not be taken lightly, and constant monitoring of patients is essential. For constant monitoring, it is important to determine the prognostic markers, but it is still not clear what factors that able to predict the transition from mild to severe/fatal illness. Several independent prognostic factors for fatal leptospirosis have been reported across the globe and these include older age, oliguria, hyperkalaemia, abnormal serum creatinine level, ARDS, pulmonary haemorrhage, elevated bilirubin level, hypotension, arrhythmia and altered mental status [8, 10, 11].
Earlier studies from Malaysia identified elevated levels of cytokines such as IL-6, IL-17A and IL-22 as potential prognostic biomarkers with IL-17A as the independent predictor for leptospirosis associated fatalities . Another study conducted in a suburban area in Malaysia identified age above 70, clinical presentations suggestive of organ dysfunction and intensive care requirement as predictors for fatalities . Fish Low et al. (2020) reported hypocalcemia (calcium < 2.10 mmol/L), hypochloremia (chloride < 98 mmol/L), and eosinopenia (absolute eosinophil count < 0.040 × 109/L) as clinical predictors for laboratory-confirmed leptospirosis when compared with clinically suspected leptospirosis cases . Analysis of a set of data for clinically diagnosed leptospirosis cases in a tertiary care hospital in Malaysia showed gastrointestinal tract (GIT) presentation as one of the predictors for severe illness and the study also found that GIT symptoms are significantly associated with age (20–40 years), poor sanitation and crowded living environment of the patients .
In the present investigation, we performed a multicentered observational study to identify factors predictive of severe leptospirosis. Determining the predictors at the early stage of the disease could greatly reduce the severe illness development and thereby mortality.
The study was conducted from January 2016 to December 2017 in three tertiary hospitals from two states in Central Malaysia: Hospital Serdang and Hospital Tengku Ampuan Rahimah (HTAR) in the state of Selangor and Hospital Teluk Intan in the state of Perak. A prospective multicenter observational study was performed on patients with clinically suspected leptospirosis. Among the 165 suspected patients, 92 were confirmed leptospirosis [1, 19]. The laboratory confirmation of these patients is defined as positive by polymerase chain reaction (PCR) or microscopic agglutination test (MAT) (first sample > 1:400; seroconversion or fourfold increase in the paired samples) . The genes used to detect the presence of leptospires in blood and serum were lipL32 and 16S rDNA [17, 18]. The samples positive by 16S rDNA were subjected to sequencing (MyTACG Bioscience Enterprise, Malaysia) to identify the infecting Leptospira species . The serovars used for MAT assay comprised of Australis, Autumnalis, Batavia, Canicola, Celledoni, Grippotyphosa, Hardjoprajitno, Icterohaemorrhagiae, Javanica, Pyrogenes, Tarrasovi, Djasiman, Patoc, Pomona (international serovars were obtained from World Health Organization (WHO)) and IMR LEP 1; saprophyte, IMR LEP 115; saprophyte, IMR LEP 175; saprophyte, IMR LEP 803/11-Copenhageni, IMR LEP 27-Hardjobovis, IMR LEP 22-Lai (local serovars were obtained from the Institute for Medical Research (IMR), Federal Territory of Kuala Lumpur, Malaysia [19, 20]. Among the 92 confirmed leptospirosis, a total of 83 patients with complete clinical admission data were recruited for classification of mild and severe (severe included dead patients) categories.
Mild illness is characterized by fever, headache, myalgia, conjunctival congestion, mild cough, lymphadenopathy, rash, anorexia, nausea and vomiting , while severe illness is defined as hospitalization plus jaundice, acute kidney injury, and or pulmonary involvement [1, 22]. The classification of mild and severe patients was based on the clinical admission data.
All data such as the socio-demography of the patients, clinical presentation and selected blood profile were entered and recorded in Excel sheet. Epi info version 7 was used for analysis. Qualitative variables were compared through χ2 test. The relationship between mild and severe cases was evaluated using logistic regression, using severe as the dependent or outcome variable. Variables which had significant finding in univariate analysis for the severe cases were further analysed by multivariable logistic regression test to predict the independent variable for severity. Only p-value less than 0.05 with a corresponding 95% confidence interval (CI) of more than one was taken as a significant result.
Overall, among the 83 positive patients, 50 were identified as mild and 33 as severe cases. A total of 57 patients were confirmed by 16S rDNA and the infecting species were identified as L. interrogans (n = 40; 48.19%), L. kirschneri (n = 16; 19.28%) and L. wolffii (n = 1; 1.20%). The socio-demography, clinical presentations and laboratory findings of all confirmed patients are shown in Table 1. The 83 patients comprised of 54 (65.06%) males and 29 (34.94%) females with a mean age of 41.92 years. Twenty patients had acute kidney injury (AKI). Of the 83 confirmed leptospirosis patients, 11 (13.25%) died and 72 (86.75%) recovered. Among the 72 patients who recovered, 22 developed severe illness based on the definition given above (case definition in the methods section).
Univariate analysis identified requirement of mechanical ventilation, AKI, septic shock, creatinine level of > 1.13 mg/dL, urea > 7 mmol/L, ALT > 50 IU, AST > 50 IU, and platelet < 150 × 109/L as significant association with severe diseases (Table 2).
Multivariable analysis on variables that showed significant association with severe cases, performed through the multivariable logistic regression analysis found that AKI with odds ratio (OR) 10.4 (1.1–100.6), ALT > 50 IU with OR 8.1 (1.2–52.5) and platelet < 150 × 109/L with OR 7.3 (1.5–33.9) were the independent risk factors associated with severity (Table 3).
The clinical manifestation and presentation of leptospirosis are broad and only specific when it becomes severe. This presents challenges to clinicians not only to make a correct diagnosis but also to give the best management and treatment to the patients to prevent progressing to severe disease and mortality. Several studies have outlined the prognostic factors associated with severe and fatal leptospirosis, however, the predictors could be different between geographical location depending on the socio-demography, type of occupation, prevailing Leptospira species, serovars and strains [8, 23].
In the present study, most leptospirosis patients were male, and this might be due to exposure-related bias where male are more involved with outdoor activities and may have occupational-related risk exposure. Patients were presented with the typical manifestation of leptospirosis such as fever, headache, myalgia and gastrointestinal involvement such as nausea and abdominal pain. Age above 70 years together with organ dysfunction has been reported as a predictor for fatality in an earlier study from Malaysia , however, we did not find any significant association with age and severity of the illness in this present study. It is undoubtedly evident that older age worsens the disease course, and the reason it was not significant for severity in our study, could be due to the low number of patients aged above 60.
Eight variables (mechanical ventilation, AKI, septic shock, creatinine level of > 1.13 mg/dL, urea > 7 mmol/L, ALT > 50 IU, AST > 50 IU, and platelet < 150 × 109/L) were found to be associated with severe illness in this study. The independent predictor of severity included AKI, ALT > 50 IU and platelet < 150 × 109/L. One of the main limitations was since the clinical data were collected only on the day of admission, we were not able to associate the time period and change in values for the predictors with the severe illness. A recent study from Malaysia also showed the association of ALT with severe leptospirosis . In addition to the increased ALT, this previous study also reported abnormal lung sounds, hepatomegaly, hypotension, leukocytosis and low hematocrit as the predictors for severe leptospirosis. We found that low platelet level as one of the predictors of severe illness, however, this factor was not suggested in the above study. This present study and two other studies in Malaysia [13, 24] showed lung involvement as one of the predictors of severity and mortality in leptospirosis. Leptospirosis patients with pulmonary hemorrhage were also reported in several case reports including travelers who visited Malaysia [25,26,27]. These factors were found to be the independent factors for mortality in studies conducted in several other countries [8, 28, 29]. Similar to the present investigation, studies from other countries have also reported the association of exaggerated AST response and higher mean of aspartate/alanine aminotransferase ratio (AAR) with severity and mortality in leptospirosis . These findings indicate that severe leptospirosis in Malaysia was characterized with multi-organs involvement. Progressive monitoring and measurements of these multi-factorial data even in patients presenting mild symptoms and with history of activities or exposure to potential source of Leptospira is vital to prevent the development of severe disease. Since these data were obtained during admission, patients are advised to seek medical treatment early if they presented with mild symptoms after jungle or water activities, exposed to flood or if working in areas with a high risk of rat infestation as the transition of mild to severe disease to fatality occur rapidly.
In our recent study, we identified two species of pathogenic and one species of intermediate Leptospira (L. interrogans, L. kirschneri and L. wolffii) causing leptospirosis in Central Malaysia with L. interrogans as the most common species . The investigation on the association between infecting species and disease outcome (severe illness) did not show any significant association.
The data obtained from the present study provides baseline information on the factors associated with severe leptospirosis and this needs to be further evaluated on a larger sample size covering different geographical locations in Malaysia and across the globe.
We identified mechanical ventilation, AKI, septic shock, creatinine level of > 1.13 mg/dL, urea > 7 mmol/L, ALT > 50 IU, AST > 50 IU, and platelet < 150 × 109/L are associated with severe illness. AKI, high level of ALT and low level of platelet were defined as the independent factors for severity.
Availability of data and materials
The raw data/datasets used and/or analysed during the current study are available from the corresponding author upon request.
Acute respiratory distress syndrome
Severe pulmonary hemorrhage syndrome
Hospital Tengku Ampuan Rahimah
Polymerase chain reaction
Microscopic agglutination test
World Health Organization
Institute for Medical Research
White blood cells
Milligrams per deciliter
Millimoles per liter
Micromoles per liter
Grams per deciliter
Aspartate/alanine aminotransferase ratio
Philip N, Affendy NB, Ramli SN, Arif M, Raja P, Nagandran E, et al. Leptospira interrogans and Leptospira kirschneri are the dominant Leptospira species causing human leptospirosis in Central Malaysia. PLoS Negl Trop Dis. 2020;14(3):e0008197.
Neela VK, Azhari NN, Joseph N, Mimie NP, Ramli SN, Mustapha NF, et al. An outbreak of leptospirosis among reserve military recruits, Hulu Perdik, Malaysia. Eur J Clin Microbiol Infect Dis. 2019;38(3):523–8.
Sejvar J, Bancroft E, Winthrop K, Bettinger J, Bajani M, Bragg S, et al. Leptospirosis in “eco-challenge” athletes, Malaysian Borneo, 2000. Emerg Infect Dis. 2003;9(6):702–7.
Koay TK, Nirmal S, Noitie L, Tan E. An epidemiological investigation of an outbreak of leptospirosis associated with swimming, Beaufort, Sabah. Med J Malaysia. 2004;59(4):455–9.
Abdullah N. Siaran media: Tindakan Kementerian Kesihatan Menangani Banjir 19 Januari 2015.http://kpkesihatan.com/2015/01/19/siaran-media-tindakankementerian-kesihatan-menangani-banjir-19-januari-2015 2015. accessed 29 June 2020.
Becirovic A, Numanovic F, Dzafic F, Piljic D. Analysis of clinical and laboratory characteristics of patients with leptospirosis in five-year period. Mater Sociomed. 2020;32(1):15–9.
Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis. 2015;9:e0003898.
Spichler AS, Vilaça PJ, Athanazio DA. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg. 2008;79(6):911–4.
Vinetz JM. Leptospirosis. Curr Opin Infect Dis. 2001;14(5):527–38.
Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis. 2002;6(1):52–9.
Dupont H, Dupont-Perdrizet D, Perie JL. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis. 1997;25(3):720–4.
Yusoff WS, Abdullah M, Sekawi Z, Amran F, Yuhana MY, Taib NM, et al. Raised levels of Il-6, Il-17a, and Il-22 in fatal leptospirosis. Eur J Clin Microbiol Infect Dis. 2019;38(12):2349–53.
Fann RJ, Vidya RR, Chong HE, Indralingam V, Chan WSC. Clinical presentations and predictors of mortality for leptospirosis- a study from suburban area in Malaysia. Med J Malaysia. 2020;75(1):52–6.
Fish-Low CY, Balami AD, Than LT, Ling KH, Taib NM, Shah AM, et al. Hypocalcemia, hypochloremia, and eosinopenia as clinical predictors of leptospirosis: a retrospective study. J Infect Public Health. 2020;13(2):216–20.
Mohd Taib N, Ahmad H, Soh KL, Md Shah A, Amin Nordin S, Than Thian Lung L, et al. Significant clinical presentation of leptospirosis in relation to sociodemographic and risk factors in a tertiary hospital, Malaysia. Vector Borne Zoonotic Dis. 2020;20(4):268–74.
Niloofa R, Fernando N, de Silva NL, Karunanayake L, Wickramasinghe H, Dikmadugudo N, et al. Diagnosis of leptospirosis: comparison between microscopic agglutination test, IgM-ELISA and IgM rapid immunochromatography test. PLoS ONE. 2015;10(6):e0129236.
Stoddard RA, Gee JE, Wilkins PP, McCaustland K, Hoffmaster AR. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targetting the lipL32 gene. Diagn Microbiol Infect Dis. 2009;64(3):247–55.
Boonsilp S, Thaipadungpanit J, Amornchai P, Wuthiekanun V, Chierakul W, Limmathurotsakul D, et al. Molecular detection and speciation of pathogenic Leptospira spp. in blood from patients with culture-negative leptospirosis. BMC Infect Dis. 2011;11:338.
Philip N, Affendy NB, Masri SN, Yuhana MY, Than LT, Sekawi Z, et al. Combined PCR and MAT improves the early diagnosis of the biphasic illness leptospirosis. PLoS ONE. 2020;15(9):e0239069.
Alia SN, Joseph N, Philip N, Azhari NN, Garba B, Masri SN, et al. Diagnostic accuracy of rapid diagnostic tests for the early detection of leptospirosis. J Infect Public Health. 2019;12(2):263–9.
Bal AM. Unusual clinical manifestations of leptospirosis. J Postgrad Med. 2005;51(3):179–83.
Chirathaworn C, Supputtamongkol Y, Lertmaharit S, Poovorawan Y. Cytokine levels as biomarkers for leptospirosis patients. Cytokine. 2016;85:80–2.
Goswami RP, Goswami RP, Basu A, Tripathi SK, Chakrabarti S, Chattopadhyay I. Predictors of mortality in leptospirosis: an observational study from two hospitals in Kolkata, eastern India. Trans R Soc Trop Med Hyg. 2014;108(12):791–6.
Sandhu RS, Ismail HB, Ja’afar MH, Rampal S. The predictive factors for severe leptospirosis cases in Kedah. Trop Med Infect Dis. 2020;5(2):79.
Lim TS, Jun TY, Fah TR. Pulmonary hemorrhage associated with severe leptospirosis—the role of low dose intravenous methylprednisolone. Mal J Med Health Sci. 2018;14(1):69–72.
Wagenaar JFP, de Vries PJ, Hartskeerl RA. Leptospirosis with pulmonary hemorrhage, caused by a new strain of serovar Lai: Langkawi. J Travel Med. 2004;11:379–82.
Leung V, Luong ML, Libman M. Leptospirosis: pulmonary hemorrhage in a returned traveller. CMAJ. 2011;183(7):E423–7.
Saarkkara A, Andrews MA. Predictors of mortality in severe leptospirosis. Int J Contemp Med. 2020;7(4):D32–7.
Bharadwaj R, Bal AM, Joshi SA, Kagal A, Pol SS, Garad G, et al. An urban outbreak of leptospirosis in Mumbai, India. Jpn J Infect Dis. 2002;60(6):194–6.
We wish to acknowledge the Ministry of Health Malaysia for reviewing and approving all the procedures involved in this study. Special thanks to all doctors, nurses and staff in Hospital Serdang and Hospital Tengku Ampuan Rahimah in Selangor state and Hospital Teluk Intan in the Perak State who helped us in recruiting patients. We also take this opportunity to thank all members of this project, for their commitment and contribution during the performance of this study. All authors thank the Director-General of Health, Malaysia for the permission to publish the finding.
This research work was supported by the Ministry of Education, Malaysia through the Long-Term Research Grant Scheme (LRGS Phase 2/2014, UPM/700-2/7/LRGS/5526400).
Ethical approval and consent to participate
The ethical clearance for this study was obtained from the Medical Research and Ethical Committee (MREC), Ministry of Health Malaysia (NMRR-15-2148-27536). Written informed consent was obtained from all patients who participated in the study.
Consent for publication
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Philip, N., Lung Than, L.T., Shah, A.M. et al. Predictors of severe leptospirosis: a multicentre observational study from Central Malaysia. BMC Infect Dis 21, 1081 (2021). https://doi.org/10.1186/s12879-021-06766-5